Beyond the Guidelines in the Treatment of Peripheral T-Cell Lymphoma: New Drug Development

Author： Chen Andy I.   Advani Ranjana H.  

Publisher： Cambridge Scholars Publishing in association with GSE Research

ISSN： 1540-1405

Source： Journal of the National Comprehensive Cancer Network (JNCCN), Vol.6, Iss.4, 2008-04, pp. : 428-435

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential of pralatrexate as a treatment of peripheral T-cell lymphoma

By Dondi Alessandra   Bari Alessia   Pozzi Samantha   Ferri Paola   Sacchi Stefano  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 5, 2014-05 ,pp. : 711-718

Informa Healthcare

Access to resources Recommend Favorite

Romidepsin: In the Treatment of T-Cell Lymphoma

By Yang Lily P.H.  

Drugs, Vol. 71, Iss. 11, 2011-07 ,pp. : 1469-1480

Adis International

Access to resources Recommend Favorite

Novel treatment avenues for peripheral T-cell lymphomas

By Hopfinger Georg   Griessl Robert   Sifft Eveline   Taylor Ninon   Kenner Lukas   Greil Richard   Merkel Olaf  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 12, 2012-12 ,pp. : 1149-1163

Informa Healthcare

Access to resources Recommend Favorite

Guidelines for the management of cutaneous T-cell lymphoma have been released in the UK.

By  

Inpharma, Vol. 1, Iss. 1420, 2004-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

X. Challenges and future directions in peripheral T‐cell lymphoma

By  

Hematological Oncology (Electronic), Vol. 33, Iss. S1, 2015-06 ,pp. : 56-61

John Wiley & Sons Inc

Access to resources Recommend Favorite